4//SEC Filing
Ambrose Kristen 4
Accession 0000875320-25-000103
CIK 0000875320other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:06 PM ET
Size
6.1 KB
Accession
0000875320-25-000103
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-02-25$480.95/sh−884$425,160→ 9,086 total - Tax Payment
Common Stock
2025-02-24$483.28/sh−828$400,156→ 9,970 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001856587
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:06 PM ET
- Size
- 6.1 KB